Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with type 2 diabetes (vol 4, pg 1543, 2003)

MJ Postma; H Kruidhof; LTWD Vanden Berg; D De Zeeuw

Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with type 2 diabetes (vol 4, pg 1543, 2003)

MJ Postma, H Kruidhof, LTWD Vanden Berg, D De Zeeuw

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1887-1887
Number of pages	1
Journal	EXPERT OPINION ON PHARMACOTHERAPY
Volume	4
Issue number	10
Publication status	Published - Oct-2003

Cite this

@article{4dc942e82d8245cf8a7ab701217a8744,

title = "Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with type 2 diabetes (vol 4, pg 1543, 2003)",

author = "MJ Postma and H Kruidhof and {Vanden Berg}, LTWD and {De Zeeuw}, D",

year = "2003",

month = oct,

language = "English",

volume = "4",

pages = "1887--1887",

journal = "EXPERT OPINION ON PHARMACOTHERAPY",

issn = "1465-6566",

publisher = "TAYLOR & FRANCIS LTD",

number = "10",

}

TY - JOUR

T1 - Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with type 2 diabetes (vol 4, pg 1543, 2003)

AU - Postma, MJ

AU - Kruidhof, H

AU - Vanden Berg, LTWD

AU - De Zeeuw, D

PY - 2003/10

Y1 - 2003/10

M3 - Article

VL - 4

SP - 1887

EP - 1887

JO - EXPERT OPINION ON PHARMACOTHERAPY

JF - EXPERT OPINION ON PHARMACOTHERAPY

SN - 1465-6566

IS - 10

ER -